Latest Insider Transactions at Pds Biotechnology Corp (PDSB)
This section provides a real-time view of insider transactions for Pds Biotechnology Corp (PDSB). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of PDS Biotechnology Corp to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of PDS Biotechnology Corp's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 02
2022
|
Frank Bedu Addo President/CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
175,184
-20.23%
|
$1,576,656
$9.78 P/Share
|
|
Dec 02
2022
|
Frank Bedu Addo President/CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
219,535
+20.22%
|
$1,317,210
$6.57 P/Share
|
|
Dec 13
2021
|
Matthew C Hill Chief Financial Officer |
BUY
Open market or private purchase
|
Indirect |
200
+2.42%
|
$1,800
$9.0 P/Share
|
|
Dec 13
2021
|
Matthew C Hill Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
2,900
+25.6%
|
$23,200
$8.95 P/Share
|
|
Jun 16
2021
|
De Lyle W Bloomquist |
BUY
Open market or private purchase
|
Direct |
10,000
+4.9%
|
$90,000
$9.88 P/Share
|
|
Jun 16
2021
|
De Lyle W Bloomquist |
BUY
Exercise of conversion of derivative security
|
Direct |
2,970
+1.59%
|
$14,850
$5.99 P/Share
|
|
Jun 15
2021
|
Gregory Gene Freitag |
BUY
Open market or private purchase
|
Direct |
5,882
+11.3%
|
$47,056
$8.5 P/Share
|
|
Jun 15
2021
|
Seth Van Voorhees Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
17,647
+50.0%
|
$141,176
$8.5 P/Share
|
|
Jun 15
2021
|
Kamil Ali Jackson |
BUY
Open market or private purchase
|
Direct |
11,764
+50.0%
|
$94,112
$8.5 P/Share
|
|
Jun 15
2021
|
Steve C Glover |
BUY
Open market or private purchase
|
Direct |
5,882
+8.44%
|
$47,056
$8.5 P/Share
|
|
Jun 15
2021
|
Frank Bedu Addo President/CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
27,166
-4.03%
|
$325,992
$12.86 P/Share
|
|
Jun 15
2021
|
Frank Bedu Addo President/CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
53,174
+7.32%
|
$319,044
$6.57 P/Share
|